Literature DB >> 3924064

Characterization of plasma lipids and lipoproteins in patients with beta 2-glycoprotein I (apolipoprotein H) deficiency.

J M Hoeg, P Segal, R E Gregg, Y S Chang, F T Lindgren, G L Adamson, M Frank, C Brickman, H B Brewer.   

Abstract

The fasting plasma lipids, lipoproteins, and apolipoproteins were evaluated in 5 subjects with undetectable levels of the plasma protein beta 2-glycoprotein I (apolipoprotein H). Family studies confirmed an autosomal co-dominant inheritance pattern for the concentrations of apo H. The total lack of this protein is rare and less than 0.3% of clinic patients demonstrated levels undetectable by radial immunodiffusion. Plasma lipoprotein evaluation in these subjects with beta 2-glycoprotein I absence by analytical ultracentrifugation and compositional analysis demonstrated low concentrations of HDL2b and HDL3. More striking, however, was the lack of a consistent marked effect on the plasma lipoproteins as is found in other apolipoprotein deficiency states. We conclude that the lack of apolipoprotein H does not result in a significant perturbation of normal lipoprotein metabolism as reflected by analysis of fasting plasma lipoproteins. Further study is required to evaluate the role of this glycoprotein in the metabolism of triglyceride-rich lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924064     DOI: 10.1016/0021-9150(85)90163-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

Review 1.  Group B Streptococcus, phospholipids and pulmonary hypertension.

Authors:  J Curtis; G Kim; N B Wehr; R L Levine
Journal:  J Perinatol       Date:  2011-04       Impact factor: 2.521

2.  Group B streptococcal phospholipid causes pulmonary hypertension.

Authors:  Jerri Curtis; Geumsoo Kim; Nancy B Wehr; Rodney L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

Review 3.  Complement in the Pathophysiology of the Antiphospholipid Syndrome.

Authors:  Shruti Chaturvedi; Robert A Brodsky; Keith R McCrae
Journal:  Front Immunol       Date:  2019-03-14       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.